Who’s in Bed with the IOM? Vitamin D Report Prompts Conflict of Interest Suspicion
The Institute of Medicine’s Nov. 30 consensus statement claiming most Americans do not need supplemental vitamin D, and that the vitamin has few benefits beyond bone health, has some folks wondering if committee members had preexisting biases or vested interests against supplementation.
It turns out that at least two members of the committee hold patents on synthetic vitamin D analogs used as prescription drugs, or have significant relationships with companies involved in vitamin D drug development.